The role of mitochondrial membrane potential in ischemic heart failure

Mitochondrion

Volumn 11, Issue 5, 2011, Pages 700-706

  Kadenbach, Bernhard ^a   Ramzan, Rabia ^a   Moosdorf, Rainer ^b   Vogt, Sebastian ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Cytochrome c oxidase; Heart ischemia reperfusion; Mitochondrial membrane potential; Protein phosphorylation; Reactive oxygen species

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ENZYME INHIBITION; ENZYME SYNTHESIS; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR DYNAMICS; NECROSIS; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ALLOSTERIC REGULATION; ANIMALS; CYTOPROTECTION; ELECTRON TRANSPORT COMPLEX IV; HEART FAILURE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, HEART; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; OXYGEN CONSUMPTION; PERMEABILITY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 79961210608     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2011.06.001     Document Type: Review

References (139)

1. Andreadou I., Iliodromitis E.K., Farmakis D., Kremastinos D.T. To prevent, protect and save the ischemic heart: antioxidants revisited. Expert Opin. Ther. Targets 2009, 13:945-956.
2. Arnold S., Kadenbach B. Cell respiration is controlled by ATP, an allosteric inhibitor of cytochrome c oxidase. Eur. J. Biochem. 1997, 249:350-354.
3. Arnold S., Kadenbach B. The intramitochondrial ATP/ADP-ratio controls cytochrome c oxidase activity allosterically. FEBS Lett. 1999, 443:105-108.
4. Arroyo C.M., Kramer J.H., Dickens B.F., Weglicki W.B. Identification of free radicals in myocardial ischemia/reperfusion by spin trapping with nitrone DMPO. FEBS Lett. 1987, 221:101-104.
5. Balaban R.S., Kantor H.L., Katz L.A., Briggs R.W. Relation between work and phosphate metabolite in the in vivo paced mammalian heart. Science 1986, 232:1121-1123.
6. Balaban R.S., Nemoto S., Finkel T. Mitochondria, oxidants, and aging. Cell 2005, 120:483-495.
7. Barnett M., Lin D., Akoyev V., Willard L., Takemoto D. Protein kinase C epsilon activates lens mitochondrial cytochrome c oxidase subunit IV during hypoxia. Exp. Eye Res. 2008, 86:226-234.
8. Bender E., Kadenbach B. The allosteric ATP-inhibition of cytochrome c oxidase is reversibly switched on by cAMP-dependent phosphorylation. FEBS Lett. 2000, 466:130-134.
9. Berkich D.A., Salama G., LaNoue K.F. Mitochondrial membrane potentials in ischemic hearts. Arch. Biochem. Biophys. 2003, 420:279-286.
10. Bienengraeber M., Ozcan C., Terzic A. Stable transfection of UCP1 confers resistance to hypoxia/reoxygenation in a heart-derived cell line. J. Mol. Cell. Cardiol. 2003, 35:861-865.
11. Blaustein M.P., Lederer W.J. Sodium/calcium exchange: its physiological implications. Physiol. Rev. 1999, 79:763-854.
12. Bolli R., Patel B.S., Jeroudi M.O., Lai E.K., McCay P.B. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J. Clin. Invest. 1988, 82:476-485.
13. Brand M.D. The efficiency and plasticity of mitochondrial energy transduction. Biochem. Soc. Trans. 2005, 33:897-904.
14. Burwell L.S., Brookes P.S. Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury. Antioxid. Redox Signal. 2008, 10:579-599.
15. Capitanio N., Capitanio G., De Nitto E., Billani G., Papa S. H+/e- stoichiometry of mitochondrial cytochrome complexes reconstituted in liposomes. Rate-dependent changes of the stoichiometry in the cytochrome c oxidase vesicles. FEBS Lett. 1991, 288:179-182.
16. Capitanio N., Capitanio G., Demarinis D.A., De Nitto E., Massari S., Papa S. Factors affecting the H+/e- stoichiometry in mitochondrial cytochrome c oxidase: influence of the rate of electron flow and transmembrane δpH+. Biochemistry 1996, 35:10800-10806.
17. Carlson K., Ehrich M. Organophosphorus compound-induced modification of SH-SY5Y human neuroblastoma mitochondrial transmembrane potential. Toxicol. Appl. Pharmacol. 1999, 160:33-42.
18. Chance B., Williams G.R. Respiratory enzymes in oxidative phosphorylation. III. The steady state. J. Biol. Chem. 1955, 217:409-427.
19. Chandel N.S., McClintock D.S., Feliciano C.E., Wood T.M., Melendez J.A., Rodriguez A.M., Schumacker P.T. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J. Biol. Chem. 2000, 275:25130-25138.
20. Chang M.C., Ho Y.S., Lee P.H., Chan C.P., Lee J.J., Hahn L.J., Wang Y.J., Jeng J.H. Areca nut extract and arecoline induced the cell cycle arrest but not apoptosis of cultured oral KB epithelial cells: association of glutathione, reactive oxygen species and mitochondrial membrane potential. Carcinogenesis 2001, 22:1527-1535.
21. Choi K., Kim J., Kim G.W., Choi C. Oxidative stress-induced necrotic cell death via mitochondira-dependent burst of reactive oxygen species. Curr. Neurovasc. Res. 2009, 6:213-222.
22. Dai D.F., Santana L.F., Vermulst M., Tomazela D.M., Emond M.J., MacCoss M.J., Gollahon K., Martin G.M., Loeb L.A., Ladiges W.C., Rabinovitch P.S. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 2009, 119:2789-2797.
23. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., Milzani A. Biomarkers of oxidative damage in human disease. Clin. Chem. 2006, 52:601-623.
24. Dalmonte M.E., Forte E., Genova M.L., Giuffrè A., Sarti P., Lenaz G. Control of respiration by cytochrome c oxidase in intact cells: role of the membrane potential. J. Biol. Chem. 2009, 284:32331-32335.
25. Date M.O., Morita T., Yamashita N., Nishida K., Yamaguchi O., Higuchi Y., Hirotani S., Matsumura Y., Hori M., Tada M., Otsu K. The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. J. Am. Coll. Cardiol. 2002, 39:907-912.
26. Di Lisa F., Bernardi P. Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc. Res. 2006, 70:191-199.
27. Downey J.M., Davis A.M., Cohen M.V. Signaling pathways in ischemic preconditioning. Heart Fail. Rev. 2007, 12:181-188.
28. Dröse S., Brandt U. The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex. J. Biol. Chem. 2008, 283:21649-21654.
29. Dröse S., Hanley P.J., Brandt U. Ambivalent effects of diazoxide on mitochondrial TOS production at respiratory chain complexes I and III. Biochim. Biophys. Acta 2009, 1790:558-565.
30. Eleuteri E., Magno F., Gnemmi I., Carbone M., Colombo M., La Rocca G., Anzalone R., Genta F.T., Zummo G., Di Stefano A., Giannuzzi P. Role of oxidative and nitrosative stress biomarkers in chronic heart failure. Front. Biosci. 2009, 14:2230-2237.
31. Fang J.-K., Prabu S.K., Sepuri N.B., Raza H., Raza H., Raza H., Anandatheerthavarada H.K., Galati D., Spear J.H., Avadhani N.G. Site specific phosphorylation of cytochrome c oxidase subunits I, IVi1 and Vb in rabbit hearts subjected to ischemia/reperfusion. FEBS Lett. 2007, 581:1302-1310.
32. Fenning A., Harrison G., Dwyer D., Meyer R.R., Brown L. Cardiac adaptation to endurance exercise in rats. Mol. Cell. Biochem. 2003, 251:51-59.
33. Ferguson-Miller S., Brautigan D.L., Margoliash E. Correlation of the kinetics of electron transfer activity of various eukaryotic cytochromes c with binding to mitochondrial cytochrome c oxidase. J. Biol. Chem. 1976, 251:1104-1115.
34. Forman H.J., Fukuto J.M., Miller T., Zhang H., Rinna A., Levy S. The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal. Arch. Biochem. Biophys. 2008, 477:183-195.
35. Fox R.M., Morgan R.M., Markham A. Calcium antagonists and Bay K8644 promote depolarization of the rat heart mitochondrial membrane potential. Further evidence for a role in alteration of oxidative metabolism. Biochem. Pharmacol. 1993, 45:1995-2001.
36. From A.H.L., Zimmer S.D., Michurski S.P., Mohanakrishnan P., Ulstad V.K., Thoma W.J., Ugurbil K. Regulation of the oxidative phosphorylation rate in the intact cell. Biochemistry 1990, 29:3731-3743.
37. Galluzzi L., Kroemer G. Necroptosis: a specialized pathway of programmed necrosis. Cell 2008, 135:1161-1163.
38. Ganote C.E., Armstrong S.C. Effects of CCCP-induced mitochondrial uncoupling and cyclosporin A on cell volume, cell injury and preconditioning protection of isolated rabbit cardiomyocytes. J. Mol. Cell. Cardiol. 2003, 35:749-759.
39. Gao L., Mann G.E. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc. Res. 2009, 82:9-20.
40. Gao Q., Wolin M.S. Effects of hypoxia on relationships between cytosolic and mitochondrial NAD(P)H redox and superoxide generation in coronary arterial smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H978-H989.
41. Garlick P.B., Davies M.J., Hearse D.J., Slater T.F. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ. Res. 1987, 61:757-760.
42. Gergely P., Niland B., Gonchoroff N., Pullmann R., Phillips P.E., Perl A. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus. J. Immunol. 2002, 169:1092-1101.
43. Giovannini C., Matarrese P., Scazzocchio B., Sanchez M., Masella R., Malorni W. Mitochondria hyperpolarization is an early event in oxidized low-density lipoprotein-induced apoptosis in Caco-2 intestinal cells. FEBS Lett. 2002, 523:200-206.
44. Greco M., Vacca R.A., Moro L., Perlino E., Petragallo V.A., Marra E., Passarella S. Helium-Neon laser irradiation of hepatocytes can trigger increase of the mitochondrial membrane potential and can stimulate c-fos expression in a Ca2+-dependent manner. Lasers Surg. Med. 2001, 29:433-441.
45. Guo D., Nguyen T., Ogbi M., Tawfik H., Ma G., Yu Q., Caldwell R.W., Johnson J.A. Protein kinase C-epsilon coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H2219-H2230.
46. Guzy R.D., Schumacker P.T. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp. Physiol. 2006, 91:807-819.
47. Hafner R.P., Brand M.D. Effect of protonmotive force on the relative proton stoichiometries of the mitochondrial proton pumps. Biochem. J. 1991, 275:75-80.
48. Haigney M.C., Lakatta E.G., Stern M.D., Silverman H.S. Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading. Circulation 1994, 90:391-399.
49. Halestrap A.P. Mitochondria and reperfusion injury of the heart - a holey death but not beyond salvation. J. Bioenerg. Biomembr. 2009, 41:113-121.
50. Halestrap A.P., Pasdois P. The role of the mitochondrial permeability transition pore in heart disease. Biochim. Biophys. Acta 2009, 1787:1402-1415.
51. Hausenloy D.J., Tsang A., Mocanu M.M., Yellon D.M. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H971-H976.
52. Helling S., Vogt S., Rhiel A., Ramzan R., Wen L., Marcus K., Kadenbach B. Phosphorylation and kinetics of mammalian cytochrome c oxidase. Mol. Cell. Proteomics 2008, 7:1714-1724.
53. Himmelreich U., Dobson G.P. Detection and quantification of free cytosolic inorganic phosphate and other phosphorus metabolites in the beating mouse heart muscle in situ. NMR Biomed. 2000, 13:467-473.
54. Hüttemann M., Kadenbach B., Grossman L.I. Mammalian subunit IV isoforms of cytochrome c oxidase. Gene 2001, 267:111-123.
55. Hüttemann M., Lee I., Pecinova A., Pecina P., Przyklenk K., Doan J.W. Regulation of oxidative phosphorylation, the mitochondrial membrane potential, and their role in human disease. J. Bioenerg. Biomembr. 2008, 40:445-456.
56. Hüttemann M., Pecina P., Rainbolt M., Sanderson T.H., Kagan V.E., Samavati L., Doan J.W., Lee I. The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: from respiration to apoptosis. Mitochondrion 2011, 11:369-381.
57. Ibi M., Matsuno K., Shiba D., Katsuyama M., Iwata K., Kakehi T., Nakagawa T., Sango K., Shirai Y., Yokoyama T., Kaneko S., Saito N., Yabe-Nishimura C. Reactive oxygen species derived from NOX1/NADPH oxidase enhance inflammatory pain. J. Neurosci. 2008, 28:9486-9494.
58. Iijima T., Mishima T., Akagawa K., Iwao Y. Mitochondrial hyperpolarization after transient oxygen-glucose deprivation and subsequent apoptosis in cultured rat hippocampal neurons. Brain Res. 2003, 993:140-145.
59. Jastroch M., Divakaruni A.S., Mookerjee S., Treberg J.R., Brand M.D. Mitochondrial proton and electron leaks. Essays Biochem. 2010, 47:53-67.
60. Joshi B., Li L., Taffe B.G., Zhu Z., Wahl S., Tian H., Ben-Josef E., Tayler J.D., Porter A.T., Tang D.G. Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial chain. Cancer Res. 1999, 59:4343-4355.
61. Kadenbach B. Intrinsic and extrinsic uncoupling of oxidative phosphorylation. Biochim. Biophys. Acta 2003, 1604:77-94.
62. Kadenbach B., Arnold S. A second mechanism of respiratory control. FEBS Lett. 1999, 447:131-134.
63. Kadenbach B., Bender E., Reith A., Becker A., Hammerschmidt S., Lee I., Arnold S., Hüttemann M. Possible influence of metabolic activity on aging. J. Anti-Aging Med. 1999, 2:255-264.
64. Kadenbach B., Hüttemann M., Arnold S., Lee I., Mühlenbein N., Bender E. Mitochondrial energy metabolism is regulated via nuclear-coded subunits of cytochrome c oxidase. Free Radic. Biol. Med. 2000, 29:211-221.
65. Kadenbach B., Arnold S., Lee I., Hüttemann M. The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases. Biochim. Biophys. Acta 2004, 1655:400-408.
66. Kadenbach B., Ramzan R., Vogt S. Degenerative diseases, oxidative stress and cytochrome c oxidase function. Trends Mol. Med. 2009, 15:139-147.
67. Kadenbach B., Ramzan R., Wen L., Vogt S. New extension of the Mitchell Theory for oxidative phosphorylation in mitochondria of living organisms. Biochim. Biophys. Acta 2010, 1800:205-212.
68. Kaim G., Dimroth P. ATP synthesis by F-type ATP synthase is obligatorily dependent on the transmembrane voltage. EMBO J. 1999, 18:4118-4127.
69. Kevin L.G., Camara A.K., Riess M.L., Novalija E., Stowe D.F. Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H566-H574.
70. Kobayashi H., Miura T., Ishida H., Miki T., Tanno M., Yano T., Sato T., Hotta H., Shimamoto K. Limitation of infarct size by erythropoietin is associated with translocation of Akt to the mitochondria after reperfusion. Clin. Exp. Pharmacol. Physiol. 2008, 35:812-819.
71. Korge P., Ping P., Weiss J.N. Reactive oxygen species production in energized cardiac mitochondria during hypoxia/reoxygenation: modulation by nitric oxide. Circ. Res. 2008, 103:873-880.
72. Korshunov S.S., Skulachev V.P., Starkov A.A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997, 416:15-18.
73. Kupriyanov V.V., Korchazhkina O.V., Lakomkin V.L. Regulation of cardiac energy turnover by coromary flow: a 31P-NMR study. J. Mol. Cell. Cardiol. 1993, 25:1235-1247.
74. Lardy H.A., Wellman H. Oxidative phosphorylations; role of inorganic phosphate and acceptor systems in control of metabolic rates. J. Biol. Chem. 1952, 195:215-224.
75. Lee I., Bender E., Arnold S., Kadenbach B. New control of mitochondrial membrane potential and ROS-formation. Biol. Chem. 2001, 382:1629-1633.
76. Lee I., Bender E., Kadenbach B. Control of mitochondrial membrane potential and ROS formation by reversible phosphorylation of cytochrome c oxidase. Mol. Cell. Biochem. 2002, 234/235:63-70.
77. Lee I., Salomon A.R., Ficarro S., Mathes I., Lottspeich F., Grossman L.I., Hüttemann M. cAMP-dependent tyrosine phosphorylation of subunit I inhibits cytochrome c oxidase activity. J. Biol. Chem. 2005, 280:6094-6100.
78. Lee I., Salomon A.R., Yu K., Samavati L., Pecina P., Pecinova A., Hüttemann M. Isolation of regulatory-competent, phosphorylated cytochrome C oxidase. Meth. Enzymol. 2009, 457:193-210.
79. Liang B.C., Miller L., Weller A. Ethyl-nitrosourea transformed astrocytes exhibit mitochondrial membrane hyperpolarization and constrained apoptosis. Apoptosis 1999, 4:89-97.
80. Lim T.S., Dávila A., Wallace D.C., Burke P. Assessment of mitochondrial membrane potential using an on-chip microelectrode in a microfluidic device. Lab Chip 2010, 10:1683-1688.
81. Lin J., Wu S., Chan S.I. Electron transfer from cytochrome c to 8-azido-ATP-modified cytochrome c oxidase. Biochemistry 1995, 34:6335-6343.
82. Lin J., Wu S., Lau W.T., Chan S. 8-Azido-ATP modification of cytochrome c: retardation of its electron-transfer activity to cytochrome c oxidase. Biochemistry 1995, 34:2678-2685.
83. Liu S.S. Generating, partitioning, targeting and functioning of superoxide in mitochondria. Biosci. Rep. 1997, 17:259-272.
84. Ludwig B., Bender E., Arnold S., Hüttemann M., Lee I., Kadenbach B. Cytochrome c oxidase and the regulation of oxidative phosphorylation. Chem. Bio. Chem. 2001, 2:392-403.
85. Lyon A.R., Joudrey P.J., Jin D., Nass R.D., Aon M.A., O'Rourke B., Akar F.G. Optical imaging of mitochondrial function uncovers actively propagating waves of mitochondrial membrane potential collapse across intact heart. J. Mol. Cell. Cardiol. 2010, 49:565-575.
86. Mansfield K., Pucci B., Adams C.S., Shapiro I.M. Induction of apoptosis in skeletal tissues: phosphate-mediated chick chondrocyte apoptosis is calcium dependent. Calcif. Tissue Int. 2003, 73:161-172.
87. Margalit R., Schejter A. Cytochrome c: a thermodynamic study of relationships among oxidation state, ion-binding and structural parameters. 2. Ion-binding linked to oxidation state. Eur. J. Biochem. 1973, 32:500-505.
88. Matsushima S., Ide T., Yamato M., Matsusaka H., Hattori F., Ikeuchi M., Kubota T., Sunagawa K., Hasegawa Y., Kurihara T., Oikawa S., Kinugawa S., Tsutsui H. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 2006, 113:1779-1786.
89. Maynard S., de Souza-Pinto N.C., Scheibye-Knudsen M., Bohr V.A. Mitochondrial base excision repair assays. Methods 2010, 51:416-425.
90. Mitchell P. Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biol. Rev. 1966, 41:445-502.
91. Miura T., Tanno M., Sato T. Mitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis. Cardiovasc. Res. 2010, 88:7-15.
92. Mollica M.P., Iossa S., Liverine G., Soboll S. Steady state changes in mitochondrial electrical potential and proton gradient in perfused liver from rats fed a high fat diet. Mol. Cell. Biochem. 1998, 178:213-217.
93. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417:1-13.
94. Murphy M.P., Brand M.D. Variable stoichiometry of proton pumping by the mitochondrial respiratory chain. Nature 1987, 329:170-172.
95. Murphy M.P., Brand M.D. The stoichiometry of charge translocation by cytochrome c oxidase and the cytochrome bc1 complex of mitochondria at high membrane potential. Eur. J. Biochem. 1988, 173:645-651.
96. Murphy E., Eisner D.A. Regulation of intracellular and mitochondrial sodium in health and disease. Circ. Res. 2009, 104:292-303.
97. Murphy E., Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 2008, 88:581-609.
98. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.
99. Neely J.R., Rovetto M.J., Whitmer J.T., Morgan H.E. Effects of ischemia on function and metabolism of the isolated working rat heart. Am. J. Physiol. 1973, 225:651-658.
100. Nishihara M., Miura T., Miki T., Sakamoto J., Tanno M., Kobayashi H., Ikeda Y., Ohori K., Takahashi A., Shimamoto K. Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H748-H755.
101. O'Brien T.M., Oliveira P.J., Wallace K.B. Inhibition of the adenine nucleotide translocator by N-acetyl perfluorooctane sulfonamides in vitro. Toxicol. Appl. Pharmacol. 2008, 227:184-195.
102. Ogbi M., Johnson J.A. Protein kinase Cepsilon interacts with cytochrome c oxidase subunit IV and enhances cytochrome c oxidase activity in neonatal cardiac myocyte preconditioning. Biochem. J. 2006, 393:191-199.
103. O'Shea P.S., Petrone G., Casey R.P., Azzi A. The current-voltage relationships of liposomes and mitochondria. Biochem. J. 1984, 219:719-726.
104. Paradies G., Petrosillo G., Paradies V., Ruggiero F.M. Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease. Cell Calcium 2009, 45:643-650.
105. Persichini T., Mazzone V., Polticelli F., Moreno S., Venturini G., Clementi E., Colasanti M. Mitochondrial type I nitric oxide synthase physically interacts with cytochrome c oxidase. Neurosci. Lett. 2005, 384:254-259.
106. Pham N.A., Hedley D.W. Respiratory chain-generated oxidative stress following treatment of leukamic blasts with DNA-damaging agents. Exp. Cell Res. 2001, 264:345-352.
107. Piacentini M., Farrace M.G., Piredda L., Matarrese P., Ciccosanti F., Falasca L., Rodolfo C., Giammarioli A.M., Verderio E., Griffin M., Malorni W. Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress. J. Neurochem. 2002, 81:1061-1072.
108. Piccoli C., Scrima R., Boffoli D., Capitanio N. Control by cytochrome c oxidase of the callular oxidative phosphorylation system depends on the mitochondrial energy state. Biochem. J. 2006, 396:573-583.
109. Pietrobon D., Zoratti M., Azzone G.F. Molecular slipping in redox and ATPase H+ pumps. Biochim. Biophys. Acta 1983, 723:317-326.
110. Piret J.P., Arnould T., Fuks B., Chatelain P., Remacle J., Michiels C. Mitochondria permeability transition-dependent tert-butyl hydroperoxide-induced apoptosis in hepatoma HepG2 cells. Biochem. Pharmacol. 2004, 67:611-620.
111. Ramzan R., Staniek K., Kadenbach B., Vogt S. Mitochondrial respiration and membrane potential are regulated by the allosteric ATP-inhibition of cytochrome c oxidase. Biochim. Biophys. Acta 2010, 1797:1672-1680.
112. Rey S., Semenza G.L. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc. Res. 2010, 86:236-242.
113. Rottenberg H., Covian R., Trumpower B.L. Membrane potential greatly enhances superoxide generation by the cytochrome bc1 complex reconstituted into phospholipid vesicles. J. Biol. Chem. 2009, 284:19203-19210.
114. Sack M.N. Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance. Cardiovasc. Res. 2006, 72:210-219.
115. Sakoff J.A., Ackland S.P. Thymidylate synthase inhibition induces S-phase arrest, biphasic mitochondrial alterations and caspase-dependent apoptosis in leukaemia cells. Cancer Chemother. Pharmacol. 2000, 46:477-487.
116. Sanchez-Alcazar J.A., Ault J.G., Khodjakov A., Schneider E. Increased mitochondrial cytochrome c levels and mitochondrial hyperpolarization precede camptothecin-induced apoptosis in Jurkat cells. Cell. Death Differ. 2000, 7:1090-1100.
117. Sedlic F., Sepac A., Pravdic D., Camara A.K., Bienengraeber M., Brzezinska A.K., Wakatsuki T., Bosnjak Z.J. Mitochondrial depolarization underlies delay in permeability transition by preconditioning with isoflurane: roles of ROS and Ca2+. Am. J. Physiol. Cell Physiol. 2010, 299:C506-C515.
118. Stadtman E.R. Protein oxidation and aging. Free Radic. Res. 2006, 40:1250-1258.
119. Stellwagen E., Shulman R.G. Nuclear magnetic resonance study of exchangeable protons in ferricytochrome c. J. Mol. Biol. 1973, 75:683-698.
120. Steverding D., Kadenbach B. Influence of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinolin modification on proton translocation and membrane potential of reconstituted cytochrome c oxidase support "proton slippage". J. Biol. Chem. 1991, 266:8097-8101.
121. Steverding D., Köhnke D., Ludwig B., Kadenbach B. Proton slippage in cytochrome c oxidase of Paracoccus denitrificans. Membrane potential measurements with the two- and three-subunit enzyme. Eur. J. Biochem. 1993, 212:827-831.
122. Taylor C.T., Moncada S. Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia. Arterioscler. Thromb. Vasc. Biol. 2010, 30:643-647.
123. Trachootham D., Lu W., Ogasawara M.A., Nilsa R.D., Huang P. Redox regulation of cell survival. Antioxid. Redox Signal. 2008, 10:1343-1374.
124. Tsutsui M., Shimokawa H., Otsuji Y., Yanagihara N. Pathophysiological relevance of NO signaling in the cardiovascular system: novel insight from mice lacking all NO synthases. Pharmacol. Ther. 2010, 128:499-508.
125. Valko M., Leibfritz D., Moncola J., Cronin M.T.D., Mazura M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell. Biol. 2007, 39:44-84.
126. Vanden Hoek T.L., Shao Z., Li C., Zak R., Schumacker P.T., Becker L.B. Reperfusion injury on cardiac myocytes after simulated ischemia. Am. J. Physiol. Heart Circ. Physiol. 1996, 270:H1334-H1341.
127. Villani G., Attardi G. In vivo control of respiration by cytochrome c oxidase in wild-type and mitochondrial DNA mutation-carrying human cells. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:1166-1171.
128. Villani G., Attardi G. In vivo measurements of respiration control by cytochrome c oxidase and in situ analysis of oxidative phosphorylation. Meth. Cell Biol. 2001, 65:119-131.
129. Vincent A.M., Brownlee M., Russell J.W. Oxidative stress and programmed cell death in diabetic neuropathy. Ann. N.Y. Acad. Sci. 2002, 959:368-383.
130. Wan B., Doumen C., Duszynski J., Salama G., Vary T.C., LaNoue K.F. Effects of cardiac work on electrical potential gradient across mitochondrial membrane in perfused rat hearts. Am. J. Physiol. 1993, 265:H453-H460.
131. Whelan R.S., Kaplinskiy V., Kitsis R.N. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu. Rev. Physiol. 2010, 72:19-44.
132. Wong R., Aponte A.M., Steenbergen C., Murphy E. Cardioprotection leads to novel changes in the mitochondrial proteome. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H75-H91.
133. Yang X., Cohen M.V., Downey J.M. Mechanism of cardioprotection by early ischemic preconditioning. Cardiovasc. Drugs Ther. 2010, 24:225-234.
134. Yellon D.M., Hausenloy D.J. Myocardial reperfusion injury. N. Engl. J. Med. 2007, 357:1121-1135.
135. Zhang H., Huang H.M., Carson R.C., Mahmood J., Thomas H.M., Gibson G.E. Assessment of membrane potentials of mitochondrial populations in living cells. Anal. Biochem. 2001, 298:170-180.
136. Zhao Z.Q. Oxidative stress-elicited myocardial apoptosis during reperfusion. Curr. Opin. Pharmacol. 2004, 4.2:159-165.
137. Zolkiewska A., Zabocka B., Duszynski J., Wojtczak L. Resting state respiration of mitochondria: reappraisal of the role of passive ion fluxes. Arch. Biochem. Biophys. 1989, 275:580-590.
138. Zweier J.L., Talukder M.A.G. The role of oxidants and free radicals in reperfusion injury. Cardiovasc. Res. 2006, 70:181-190.
139. Zweier J.L., Flaherty J.T., Weisfeldt M.L. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:1404-1407.